HIGHLIGHTS
- who: Wouter M. Sluis and collaborators from the Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands have published the paper: Preventive ceftriaxone in patients at high risk of stroke-associated pneumonia. A post-hoc analysis of the PASS trial, in the Journal: PLOS ONE of December/13,/2022
- what: For the current study, baseline demographics, comorbidities, stroke type and data on dysphagia assessment were collected. This study has a co-primary outcome: pneumonia rate (as assessed by the treating physician) and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.